Regulation of S100A2 expression by TGF-β-induced MEK/ERK signalling and its role in cell migration/invasion

Biochemical Journal

Volumn 447, Issue 1, 2012, Pages 81-91

  Naz, Sarwat ^a   Ranganathan, Prathibha ^a   Bodapati, Priyanka ^a   Shastry, Arun H ^b   Mishra, Laxmi N ^c   Kondaiah, Paturu ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^c JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

Activator protein 1 (AP 1); HaCaT cell; Hep3B cell; p53 protein; S100 protein; SMAD binding element

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALCIUM BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROTEIN P53; PROTEIN S 100 A2; SMAD3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; EPITHELIUM CELL; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR CELL; TUMOR PROMOTION;

CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOTACTIC FACTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-JUN; RNA, SMALL INTERFERING; S100 PROTEINS; TRANSCRIPTION FACTOR AP-1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84866419837     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120014     Document Type: Article

References (45)

1. Salama, I., Malone, P. S., Mihaimeed, F. and Jones, J. L. (2008) A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 34, 357-364
2. Wolf, S., Haase-Kohn, C. and Pietzsch, J. (2011) S100A2 in cancerogenesis: a friend or a foe? Amino Acids 41, 849-861
3. Micci, F., Teixeira, M. R., Haugom, L., Kristensen, G., Abeler, V. M. and Heim, S. (2004) Genomic aberrations in carcinomas of the uterine corpus. Genes Chromosomes Cancer 40, 229-246
4. Xie, R., Loose, D. S., Shipley, G. L., Xie, S., Bassett, Jr, R. L. and Broaddus, R. R. (2007) Hypomethylation-induced expression of S100A4 in endometrial carcinoma. Mod. Pathol. 20, 1045-1054
5. Imazawa, M., Hibi, K., Fujitake, S., Kodera, Y., Ito, K., Akiyama, S. and Nakao, A. (2005) S100A2 overexpression is frequently observed in esophageal squamous cell carcinoma. Anticancer. Res. 25, 1247-1250
6. Komatsu, K., Kobune-Fujiwara, Y., Andoh, A., Ishiguro, S., Hunai, H., Suzuki, N., Kameyama, M., Murata, K., Miyoshi, J., Akedo, H. et al. (2000) Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. Br. J. Cancer 83, 769-774
7. Lee, S. W., Tomasetto, C., Swisshelm, K., Keyomarsi, K. and Sager, R. (1992) Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc. Natl. Acad. Sci. U.S.A. 89, 2504-2508
8. McKiernan, E., McDermott, E. W., Evoy, D., Crown, J. and Duffy, M. J. (2011) The role of S100 genes in breast cancer progression. Tumour Biol. 32, 441 - 450
9. Hough, C. D., Cho, K. R., Zonderman, A. B., Schwartz, D. R. and Morin, P. J. (2001) Coordinately up-regulated genes in ovarian cancer. Cancer Res. 61, 3869-3876
10. Diederichs, S., Bulk, E., Steffen, B., Ji, P., Tickenbrock, L., Lang, K., Zanker, K. S., Metzger, R., Schneider, P. M., Gerke, V. et al. (2004) S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res. 64, 5564-5569
11. 2+-binding S100 proteins in epithelial tumours of the skin. Virchows Arch. 432, 53-59
12. Kyriazanos, I. D., Tachibana, M., Dhar, D. K., Shibakita, M., Ono, T., Kohno, H. and Nagasue, N. (2002) Expression and prognostic significance of S100A2 protein in squamous cell carcinoma of the esophagus. Oncol. Rep. 9, 503-510
13. Xie, R., Schlumbrecht, M. P., Shipley, G. L., Xie, S., Bassett, Jr, R. L. and Broaddus, R. R. (2009) S100A4 mediates endometrial cancer invasion and is a target of TGF-β1 signaling. Lab. Invest. 89, 937-947
14. Ranganathan, P., Agrawal, A., Bhushan, R., Chavalmane, A. K., Kalathur, R. K., Takahashi, T. and Kondaiah, P. (2007) Expression profiling of genes regulated by TGF-β: differential regulation in normal and tumour cells. BMC Genomics 8, 98
15. Foser, S., Redwanz, I., Ebeling, M., Heizmann, C. W. and Certa, U. (2006) Interferon-α and transforming growth factor-β co-induce growth inhibition of human tumor cells. Cell. Mol. Life Sci. 63, 2387-2396
16. Inman, G. J. (2011) Switching TGF-β from a tumor suppressor to a tumor promoter. Curr. Opin. Genet. Dev. 21, 93-99
17. Derynck, R. and Zhang, Y. E. (2003) Smad-dependent and Smad-independent pathways in TGF-β family signaling. Nature 425, 577-584
18. Meulmeester, E. and Ten Dijke, P. (2011) The dynamic roles of TGF-β in cancer. J. Pathol. 223, 205-218
19. Arany, P. R., Nayak, R. S., Hallikerimath, S., Limaye, A. M., Kale, A. D. and Kondaiah, P. (2007) Activation of latent TGF-β1 by low-power laser in vitro correlates with increased TGF-β1 levels in laser-enhanced oral wound healing. Wound Repair. Regen. 15, 866-874
20. Reddy, S. P., Britto, R., Vinnakota, K., Aparna, H., Sreepathi, H. K., Thota, B., Kumari, A., Shilpa, B. M., Vrinda, M., Umesh, S. et al. (2008) Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis. Clin. Cancer Res. 14, 2978-2987
21. Somasundaram, K. and El-Deiry, W. S. (1997) Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene 14, 1047-1057
22. Bulk, E., Sargin, B., Krug, U., Hascher, A., Jun, Y., Knop, M., Kerkhoff, C., Gerke, V., Liersch, R., Mesters, R. M. et al. (2009) S100A2 induces metastasis in non-small cell lung cancer. Clin. Cancer Res. 15, 22-29
23. Ikebe, D., Wang, B., Suzuki, H. and Kato, M. (2007) Suppression of keratinocyte stratification by a dominant negative JunB mutant without blocking cell proliferation. Genes Cells 12, 197-207
24. Bahadur, U., Ganjam, G. K., Vasudevan, N. and Kondaiah, P. (2005) Estrogen regulation of chicken riboflavin carrier protein gene is mediated by ERE half sites without direct binding of estrogen receptor. Mol. Cell. Endocrinol. 231, 1-11
25. Zawel, L., Dai, J. L., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B. and Kern, S. E. (1998) Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611-617
26. Wicki, R., Franz, C., Scholl, F. A., Heizmann, C. W. and Schafer, B. W. (1997) Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium 22, 243-254
27. Guo, B., Inoki, K., Isono, M., Mori, H., Kanasaki, K., Sugimoto, T., Akiba, S., Sato, T., Yang, B., Kikkawa, R. et al. (2005) MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-β in rat mesangial cells. Kidney Int. 68, 972-984
28. Hall, M. C., Young, D. A., Waters, J. G., Rowan, A. D., Chantry, A., Edwards, D. R. and Clark, I. M. (2003) The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-β. J. Biol. Chem. 278, 10304-10313
29. Tapias, A., Ciudad, C. J. and Noe, V. (2008) Transcriptional regulation of the 5′-flanking region of the human transcription factor Sp3 gene by NF-1, c-Myb, B-Myb, AP-1 and E2F. Biochim. Biophys. Acta 1779, 318-329
30. Hess, J., Angel, P. and Schorpp-Kistner, M. (2004) AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117, 5965-5973
31. Herr, I. and Debatin, K. M. (2001) Cellular stress response and apoptosis in cancer therapy. Blood 98, 2603-2614
32. Ameyar, M., Wisniewska, M. and Weitzman, J. B. (2003) A role for AP-1 in apoptosis: the case for and against. Biochimie 85, 747-752
33. Elkeles, A., Juven-Gershon, T., Israeli, D., Wilder, S., Zalcenstein, A. and Oren, M. (1999) The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor. Mol. Cell. Biol. 19, 2594-2600
34. Caja, L., Bertran, E., Campbell, J., Fausto, N. and Fabregat, I. (2011) The transforming growth factor-β (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells. J. Cell. Physiol 226, 1214-1223
35. + breast cancer cells. Cell Cycle 10, 4149-4161
36. Matsuura, I., Chiang, K. N., Lai, C. Y., He, D., Wang, G., Ramkumar, R., Uchida, T., Ryo, A., Lu, K. and Liu, F. (2010) Pin1 promotes transforming growth factor-β -induced migration and invasion. J. Biol. Chem. 285, 1754-1764
37. Wang, H., Zhang, Z., Li, R., Ang, K. K., Zhang, H., Caraway, N. P., Katz, R. L. and Jiang, F. (2005) Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer. Int. J. Cancer 116, 285-290
38. Sakaguchi, M., Miyazaki, M., Sonegawa, H., Kashiwagi, M., Ohba, M., Kuroki, T., Namba, M. and Huh, N. H. (2004) PKCα mediates TGF-β-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11. J. Cell. Biol. 164, 979-984
39. Stoll, S. W., Zhao, X. and Elder, J. T. (1998) EGF stimulates transcription of CaN19 (S100A2) in HaCaT keratinocytes. J. Invest. Dermatol. 111, 1092-1097
40. Wang, S. E., Narasanna, A., Whitell, C. W., Wu, F. Y., Friedman, D. B. and Arteaga, C. L. (2007) Convergence of p53 and transforming growth factor β (TGF-β) signaling on activating expression of the tumor suppressor gene maspin in mammary epithelial cells. J. Biol. Chem. 282, 5661-5669
41. Niemantsverdriet, M., de Jong, E., Langendijk, J. A., Kampinga, H. H. and Coppes, R. P. (2010) Synergistic induction of profibrotic PAI-1 by TGF-β and radiation depends on p53. Radiother. Oncol. 97, 33-35
42. Liberati, N. T., Datto, M. B., Frederick, J. P., Shen, X., Wong, C., Rougier-Chapman, E. M. and Wang, X. F. (1999) Smads bind directly to the Jun family of AP-1 transcription factors. Proc. Natl. Acad. Sci. U.S.A. 96, 4844-4849
43. Cordenonsi, M., Montagner, M., Adorno, M., Zacchigna, L., Martello, G., Mamidi, A., Soligo, S., Dupont, S. and Piccolo, S. (2007) Integration of TGF-α and Ras/MAPK signaling through p53 phosphorylation. Science 315, 840-843
44. Jamieson, N. B., Carter, C. R., McKay, C. J. and Oien, K. A. (2011) Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Clin. Cancer Res. 17, 3316-3331
45. Zech, V. F., Dlaska, M., Tzankov, A. and Hilbe, W. (2006) Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100A2 in non-small cell lung cancer. Cancer Detect. Prev. 30, 395-402